The purpose of this study is to compare the safety and effectiveness of the two different
basal insulins commonly used for basal blood sugar control in the treatment of type 2
diabetes mellitus in patients who are hospitalized and require low doses of insulin: neutral
protamine Hagedorn (NPH) insulin and glargine (Lantus®) insulin. Previous research has shown
that both NPH insulin and glargine (Lantus®) insulin is safe and effective for the control of
blood sugar in a type 2 diabetic patient. This research is being done because the costs of
medications for diabetic patients are very expensive. Our goal with this research is to show
that a less expensive insulin (NPH) is as safe and effective as a more expensive insulin
[glargine (Lantus®)] in patients with type 2 diabetes mellitus who are in the hospital.
Phase:
N/A
Details
Lead Sponsor:
Inova Health Care Services
Treatments:
Insulin Insulin Glargine Insulin, Globin Zinc Isophane Insulin, Human